Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward

In response to an ongoing nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) epidemic, and in anticipation of a continuous increase of its prevalence in the near future, the American Gastroenterological Association (AGA) together with the Endocrine Society, the American Association of Clinical Endocrinologists (AACE) and other outstanding medical associations organized last summer a virtual conference of international experts in gastroenterology, endocrinology and primary care, and initiated an ongoing collaborative project, in the context of the ‘Call to Action Meeting’ [1].